Postocclusive reactive hyperemia inversely correlates with urinary 15-F2t-isoprostane levels in systemic sclerosis

Abstract Microvascular dysfunction and increased oxidative stress are major hallmarks of the systemic sclerosis disease process. The primary objective of this study was to test whether there is a link between peak postocclusive hyperemia and urinary levels of the F 2 -isoprostane 15-F 2t -IsoP (8-iso-PGF 2α ) in patients suffering from systemic sclerosis. We enrolled 43 patients suffering from systemic sclerosis, 33 patients with primary Raynaud’s phenomenon (RP), and 25 healthy volunteers. Microvascular function was assessed using the postocclusive hyperemia monitored by laser Doppler flowmetry. Endothelium-independent response was monitored after 0.4 mg sublingual nitroglycerin. Oxidative stress status was assessed by urinary levels of the F 2 -isoprostane 15-F 2t -IsoP using GC–MS. The peak postocclusive vascular conductance was altered in subjects with systemic sclerosis and primary RP compared to controls (respectively 28 (7–48), 30 (13–48), and 39.9 (13–63) mV/mm Hg, p  = 0.01). F 2 -isoprostanes were increased in the systemic sclerosis group compared to primary Raynaud’s phenomenon and healthy controls (respectively 230 (155–387), 182 (101–284), and 207 (109–291) pg/mg, p  = 0.006). In patients suffering from systemic sclerosis, there was a significant inverse correlation between F 2 -isoprostanes and postocclusive hyperemia, expressed as raw data ( R  = −0.45, p  = 0.007) or as an increase over baseline ( R  = −0.28, p  = 0.04). Conversely, no correlation was found with the nitroglycerin response. In conclusion, we provide evidence that there is an inverse correlation between postocclusive hyperemia and urinary F 2 -isoprostane levels in patients suffering from systemic sclerosis. Whether oxygen free radicals initiate the vascular dysfunction or whether there is an initial trigger that initiates both processes will need to be further clarified in future studies.